Philipp E. Bartko

Medical University of Vienna

H指数:34

被引数:4,013

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Memory of the renin-angiotensin system following heart transplantation or implantation of a left ventricular assist device

心脏移植或左心室辅助装置植入后肾素-血管紧张素系统的记忆

Clinical Research in Cardiology

IF3.7

2026-09-220

OAAI

The ELASTA-T Technique for TTVR After Failed T-TEER

ELASTA-T技术用于T-TEER失败后的TTVR

JACC: Cardiovascular Interventions

IF0

2026-06-220

PRE

Atrial Functional Mitral Regurgitation

房性功能二尖瓣反流

JACC

IF0

2026-03-180

PRE

Right Atrial-to-Right Ventricular Area Prognostic Value in Patients With Secondary Tricuspid Regurgitation and Heart Failure

右房-右室面积比在继发性三尖瓣反流合并心力衰竭患者中的预后价值

JACC-ADVANCES

IF0

2025-11-010

OAAI

Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis

严重主动脉瓣狭窄患者中伴有和不伴有心脏淀粉样变性患者的钙化评分分析

JACC: Cardiovascular Imaging

IF0

2025-10-280

PRE

Matteo Serenelli; Paolo Cimaglia; Aldostefano Porcari; Andrea Lalario; Marco Merlo; Christian Nitsche; Maximilian Autherith; Laurenz Hauptmann; Philipp Emanuel Bartko; Simone Longhi; Giulia Saturi; Fabio Vagnarelli; Carla Lofiego; Rita Conti; Alberto Aimo; Michele Emdin; Francesco Cappelli; Giulia Nardi; Alberico Del Torto; Gianluca Pontone; Guglielmo Gallone; Gaetano Maria De Ferrari; Arianna Morena; Valentino Santori; Carlo Tumscitz; Beatrice Dal Passo; Anna Cantone; Jacopo Bonini; Matteo Arzenton; Federico Sanguettoli; Federico Marchini; Rita Pavasini; Gianluca Campo; Gianfranco Sinagra

Amyloid-specific medication in transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis of cardiovascular outcome trials

转甲状腺素蛋白淀粉样变性心肌病中的淀粉样蛋白特异性药物治疗：心血管结局试验的系统评价和Meta分析

Journal of Cardiac Failure

IF8.2

2025-08-300

OAAI

Left ventricular ejection fraction and benefit of tricuspid valve interventions – insights from the international TRIGISTRY

左心室射血分数及三尖瓣干预的获益——来自国际TRIGISTRY的见解

European Journal of Heart Failure

IF10.8

2025-08-300

PRE

Gregor Heitzinger; Julien Dreyfus; Varius Dannenberg; Yan Topilsky; Giovanni Benfari; Nina Ajmone Marsan; Maurizio Taramasso; Giulio Russo; Yohann Bohbot; Christos Iliadis; Marcel Weber; Luis Nombela-Franco; Andrea Eixerés-Esteve; Baptiste Bazire; Bernard Iung; Jean-François Obadia; Rodrigo Estevez Loureiro; Elisabeth Riant; Erwan Donal; Gilbert Habib; Yoan Lavie-Badie; Jörg Hausleiter; Lucas Stolz; Luigi Badano; Thierry Le Tourneau; Augustin Coisne; Thomas Modine; Fabien Praz; Jose Luis Zamorano; Ralph Stephan von Bardeleben; Rebecca T. Hahn; Neil Fam; Horst Sievert; Denisa Muraru; Mariana Adamo; Samuel Heuts; Mohammed Nejjari; Vincent Chan; Michele De Bonis; Manuel Carnero-Alcazar; Volker Rudolph; Juan Crestanello; Philipp Lurz; Jeroen Bax; Roja Gauda; Jordan Bernick; George A. Wells; Francesco Maisano; Maurice Enriquez-Sarano; Philipp Bartko; David Messika-Zeitoun; for the TRIGISTRY Investigators

Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF Registry

射血分数降低的心力衰竭不同阶段药物治疗实施：VIENNA-HF登记研究的分析

Biomedicines 2025, Vol. 13, Page 1846

IF3.9

2025-08-210

PRE

Association between CMR-derived hepatic T1-time, tricuspid regurgitation and survival

CMR衍生的肝T1时间、三尖瓣反流与生存之间的关联

European Journal of Clinical Investigation

IF3.6

2025-08-080